Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AVEO PHARMACEUTICALS, INC. has filed 1,019 SEC EDGAR filings since 27 Apr 2005

SEC filing history

Showing 51-75 of 1,000 matching filings.

Per page
25
Current page
3
S-8 File 333-266549

S-8

Filing date
05 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A

Filing date
13 May 2022
Reporting date
10 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34655

DEFA14A

Filing date
26 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34655

DEF 14A

Filing date
26 Apr 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-34655

PRE 14A

Filing date
14 Apr 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .